MY108554A - Peptide derivatives. - Google Patents

Peptide derivatives.

Info

Publication number
MY108554A
MY108554A MYPI89000450A MYPI19890450A MY108554A MY 108554 A MY108554 A MY 108554A MY PI89000450 A MYPI89000450 A MY PI89000450A MY PI19890450 A MYPI19890450 A MY PI19890450A MY 108554 A MY108554 A MY 108554A
Authority
MY
Malaysia
Prior art keywords
sugar residue
amino group
attached
peptide
calcitonin peptide
Prior art date
Application number
MYPI89000450A
Other languages
English (en)
Inventor
Francois Cardinaux Dr
Bauer Wilfried
Rainer Albert Dr
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808275A external-priority patent/GB8808275D0/en
Priority claimed from GB888808528A external-priority patent/GB8808528D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of MY108554A publication Critical patent/MY108554A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
MYPI89000450A 1988-04-08 1989-04-08 Peptide derivatives. MY108554A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808275A GB8808275D0 (en) 1988-04-08 1988-04-08 New calcitonin derivatives
GB888808528A GB8808528D0 (en) 1988-04-12 1988-04-12 Peptide derivatives

Publications (1)

Publication Number Publication Date
MY108554A true MY108554A (en) 1996-10-31

Family

ID=26293749

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI89000450A MY108554A (en) 1988-04-08 1989-04-08 Peptide derivatives.

Country Status (19)

Country Link
US (1) US5541159A ( )
JP (2) JPH01305099A ( )
AT (1) ATA900689A ( )
AU (2) AU3362889A ( )
BE (1) BE1004357A4 ( )
CH (1) CH682152A5 ( )
DK (1) DK163689A ( )
ES (1) ES2015645A6 ( )
FR (1) FR2629825B1 ( )
GB (1) GB2218102B ( )
IE (1) IE930109L ( )
IL (1) IL89881A ( )
IT (1) IT1235894B ( )
LU (1) LU87495A1 ( )
MY (1) MY108554A ( )
NL (1) NL8900864A ( )
NZ (1) NZ228677A ( )
SE (1) SE8901241L ( )
WO (1) WO1989009786A1 ( )

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK163689A (da) * 1988-04-08 1989-10-30 Sandoz Ag Peptidderivater
DE3842010A1 (de) * 1988-12-14 1990-06-21 Hoechst Ag Kompetitive gonadoliberin-antagonisten
US5364840A (en) * 1989-12-05 1994-11-15 Vical, Inc. Synthetic calcitonin peptides
DE59100945D1 (de) * 1990-08-04 1994-03-10 Hoechst Ag Gonadoliberin-Antagonisten.
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
EP0632813B1 (en) * 1992-02-13 1999-12-15 Torf Establishment Amadori reaction compounds and products, process for their manufacture, and their use
WO1993016087A2 (en) * 1992-02-13 1993-08-19 Torf Establishment Amadori reaction compounds and products, process for their manufacture, and their use
FR2695391B1 (fr) * 1992-09-04 1994-10-14 Centre Nat Rech Scient Glycopeptides, leur procédé d'obtention, et leurs applications biologiques.
CA2123144A1 (en) * 1993-05-10 1994-11-11 David Bodmer Stabilisation of pharmacologically active compounds in sustained release compositions
WO1994028015A1 (en) * 1993-05-20 1994-12-08 Biotech Australia Pty. Limited Lhrh antagonists
SI9420051A (en) * 1993-08-09 1996-12-31 Biomeasure Inc Chemical modified peptide derivatives, process for their preparation and their use in human therapy
US5698672A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Synthetic calcitonin mimetics
US5698521A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Native calcitonin mimetics
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
US6239108B1 (en) 1996-07-11 2001-05-29 Biogen, Inc. Cell adhesion inhibitors
US6686350B1 (en) 1996-07-25 2004-02-03 Biogen, Inc. Cell adhesion inhibitors
DE69737769T2 (de) 1996-07-25 2008-05-15 Biogen Idec Ma Inc., Cambridge Molekülmodell für vla-4-inhibitoren
US6083480A (en) 1997-05-01 2000-07-04 Diatide, Inc. Calcitonin receptor binding reagents
JP4372345B2 (ja) 1998-02-13 2009-11-25 アミリン・ファーマシューティカルズ，インコーポレイテッド 新規な混合アミリン活性化合物
NZ509199A (en) 1998-05-28 2003-10-31 Biogen Inc A VLA-4 inhibitor: oMePUPA-V
CZ2002518A3 (cs) 1999-08-13 2002-05-15 Biogen, Inc. Inhibitory buněčné adheze a farmaceutické prostředky, které je obsahují
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US6875743B1 (en) 2000-11-28 2005-04-05 Biogen, Inc. Cell adhesion inhibitors
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7196112B2 (en) 2004-07-16 2007-03-27 Biogen Idec Ma Inc. Cell adhesion inhibitors
BRPI0920246A2 (pt) 2008-10-17 2017-06-27 Winconsin Alumni Res Foundation método de preparação de alfa-beta peptídios biologicamente ativos.
GB201813677D0 (en) * 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
TW202320857A (zh) * 2021-07-06 2023-06-01 美商普方生物製藥美國公司 連接子、藥物連接子及其結合物及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956260A (en) * 1967-11-09 1976-05-11 Ciba-Geigy Corporation Hypocalcaemic peptides and processes for their manufacture
JPS51128993A (en) * 1975-05-01 1976-11-10 Tanpakushitsu Kenkyu Shiyoureikai Process for preparing new polypeptides
US4650854A (en) * 1985-06-06 1987-03-17 Usv Pharmaceutical Corporation Amide analogs of calcitonin
HUT44794A (en) * 1985-12-04 1988-04-28 Sandoz Ag Process for production of calcitonine-derivatives and medical preparatives containing such compounds
DE3634435A1 (de) * 1986-10-09 1988-04-14 Hoechst Ag Analoga von gonadoliberin mit verbesserter loeslichkeit, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
DK163689A (da) * 1988-04-08 1989-10-30 Sandoz Ag Peptidderivater

Also Published As

Publication number Publication date
GB2218102B (en) 1992-09-16
AU3362889A (en) 1989-11-03
US5541159A (en) 1996-07-30
ATA900689A (de) 1997-01-15
DK163689A (da) 1989-10-30
CH682152A5 ( ) 1993-07-30
IT1235894B (it) 1992-11-23
IL89881A (en) 1994-05-30
FR2629825B1 (fr) 1993-05-14
JPH01305099A (ja) 1989-12-08
NL8900864A (nl) 1989-11-01
GB8907652D0 (en) 1989-05-17
SE8901241D0 (sv) 1989-04-07
GB2218102A (en) 1989-11-08
BE1004357A4 (fr) 1992-11-10
LU87495A1 (fr) 1989-11-14
FR2629825A1 (fr) 1989-10-13
IT8947823A0 (it) 1989-04-07
IL89881A0 (en) 1989-12-15
JPH0789994A (ja) 1995-04-04
NZ228677A (en) 1994-08-26
AU3263789A (en) 1989-10-12
DK163689D0 (da) 1989-04-05
SE8901241L (sv) 1990-02-02
IE930109L (en) 1989-10-08
WO1989009786A1 (en) 1989-10-19
ES2015645A6 (es) 1990-09-01
AU623385B2 (en) 1992-05-14

Similar Documents

Publication Publication Date Title
MY108554A (en) Peptide derivatives.
ES2007418A6 (es) Procedimiento para preparar un derivado azucar de un peptido biologicamente activo.
CA2018714A1 (en) Hypothalamic polypeptides with adenylate cyclase stimulating activity
ES2023533A6 (es) Procedimiento para la preparacion de un peptido de somatostatina.
ES2134799T3 (es) Anticuerpos monoclonales contra sitios de union inducidos por un receptor.
CA2168113A1 (en) Therapeutic peptide derivatives
EP0673255A4 (en) MONOCLONAL ANTIBODY, WHICH SPECIFICALLY BINDS TO VASCULARIZED TUMOR DOTHELIUM AND USES THEREOF.
CA2032499A1 (en) Polypeptide derivatives
GR79805B ( )
IL113617A0 (en) Soluble polypeptide fraction
DE69132275T2 (de) Beta-type ähnlicher transformierender wachstumfaktor
IL101648A0 (en) Bradykinin antagonist peptides
BG104539A (en) Ifnar-2/ifn complex
EP0751149A3 (en) Replacement analogs for magainin peptides containing phenylanaline residue
CA2067136A1 (en) Growth hormone antagonists
AU4157501A (en) Her-2 binding antagonists
CA2178635A1 (en) Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form
NZ209246A (en) Monoclonal hormone antibody formulations which potentiate or mimic hormone administration in vertebrates
AU8530891A (en) 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases
ZA916918B (en) Amino acid analogs as CCK antagonists.
EP0293130A3 (en) Dimers of parathyroid hormone antagonists
ES285467U (es) Dispositivo de fijacion de cangilones sobre la bada de un transportador, especialmente de un elevador a cangilones
ES2009274A6 (es) Sintesis de glicoencefalinas derivadas de hyp5.
MY102979A (en) Peptide derivatives
Baxter Detroit Takes Hard Look at Ceramic Applications